📰 Iodine Software News
Iodine Software News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iodine Software. Real-time updates on events, politics, business and more.
December 14, 2023
Will General Catalyst’s plans for health system acquisition come to fruition in 2024? Will GenAI live up to its hype as healthcare’s ultimate complexity liberator?
October 23, 2023
In the second part of the Heard at HLTH series, executives from BrightInsight, Iodine Software, Intelligent Medical Objects, Carrum Health, Clarify Health and Trayt Health shared new developments across their businesses and perspectives on value-based care at the HLTH 2023 event.
October 4, 2023
Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business
August 24, 2023
BOSTON and NEW YORK, Aug. 24, 2023 /PRNewswire/ -- Advent International , one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth...
July 7, 2023
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
July 3, 2023
Iodine Software recently announced that it is expanding its relationship with OpenAI. By doing so, Iodine will integrate the latest GPT-4 language model into its existing AI technologies and datasets, specifically its AwareCDI product suite.
June 30, 2023
The company says it will infuse generative AI and large language models across the breadth of its AwareCDI product suite to streamline physician administrative burdens and to help hospitals and health systems capture more earned revenue.
June 29, 2023
Iodine Software, a pioneer in healthcare AI technology, today announced an expanded relationship withOpenAI, an AI research an…
May 18, 2023
Utica, New York (PRWEB) May 18, 2023 -- JETNETwill display their innovative training courses and their research products at the European Business Aviation
May 9, 2023
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a ...